Early high‐dose aflibercept 8 mg clinical outcomes in wet age‐related macular degeneration patients resistant to aflibercept 2 mg or faricimab
Acta Ophthalmologica | August 3, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available
10.1111/aos.70213
| PMID 42544785